UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study

Head & neck, 2021-11, Vol.43 (11), p.3408-3416

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Cancer, 2020-01, Vol.126 (2), p.354-362

2020

Link zum Volltext

Verfügbarkeit prüfen

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection

Head & neck, 2023-01, Vol.45 (1), p.212-224

2023

Link zum Volltext

Verfügbarkeit prüfen

Differential expression and prognostic value of long non‐coding RNA in HPV‐negative head and neck squamous cell carcinoma

Head & neck, 2018-07, Vol.40 (7), p.1555-1564

2018

Link zum Volltext

Verfügbarkeit prüfen

Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors

The Laryngoscope, 2021-07, Vol.131 (7), p.E2413-E2419

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective

Cancer medicine (Malden, MA), 2020-09, Vol.9 (17), p.6141-6146

2020

Link zum Volltext

Verfügbarkeit prüfen

Papillomavirus E6 and E7 proteins and their cellular targets

Frontiers in bioscience, 2008-01, Vol.13, p.1003

2008

Link zum Volltext

Verfügbarkeit prüfen

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy

Frontiers in immunology, 2023-03, Vol.14, p.1184007-1184007

2023

Link zum Volltext

Verfügbarkeit prüfen

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3217

2024

Link zum Volltext

Verfügbarkeit prüfen

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e005632

2022

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Molecular and Cellular Biology, 2006-10, Vol.26 (20), p.7506-7519

2006

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1792-1799

2009

Link zum Volltext

Verfügbarkeit prüfen

Managing Recurrent Metastatic Head and Neck Cancer

Hematology/oncology clinics of North America, 2021-10, Vol.35 (5), p.1009-1020

2021

Link zum Volltext

Verfügbarkeit prüfen

Future directions and treatment strategies for head and neck squamous cell carcinomas

Translational research : the journal of laboratory and clinical medicine, 2012-09, Vol.160 (3), p.167-177

2012

Link zum Volltext

Verfügbarkeit prüfen

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Journal of Virology, 2005-11, Vol.79 (22), p.14309-14317

2005

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Clinical cancer research, 2023-05, Vol.29 (10), p.1906-1915

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2022-08, Vol.28 (16), p.3464-3472

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia

Haematologica (Roma), 2023-03, Vol.108 (3), p.705-716

2023

Link zum Volltext

Verfügbarkeit prüfen

Improving Radiotherapy Response in the Treatment of Head and Neck Cancer

Critical reviews in oncogenesis, 2022, Vol.27 (2), p.73

2022

Link zum Volltext

Verfügbarkeit prüfen

A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

Targeted oncology, 2017-06, Vol.12 (3), p.323-332

2017

Link zum Volltext

Verfügbarkeit prüfen

Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges

American Society of Clinical Oncology educational book, 2022-04, Vol.42 (42), p.1-540

2022

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole

Cancer chemotherapy and pharmacology, 2022-10, Vol.90 (4), p.345-356

2022

Link zum Volltext

Verfügbarkeit prüfen

The human DEK oncogene regulates DNA damage response signaling and repair

Nucleic acids research, 2011-09, Vol.39 (17), p.7465

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Oncology
(18)
Female
(13)
Male
(12)
Middle Aged
(11)
Aged
(10)
Cancer
(9)
Cell Line, Tumor
(9)
Immunotherapy
(9)
Squamous Cell Carcinoma
(8)
Tumors
(8)
Animals
(7)
Head And Neck Cancer
(7)
Human Papillomavirus
(7)
Biochemistry & Molecular Biology
(6)
Chemotherapy
(6)
Head And Neck Neoplasms - Drug Therapy
(6)
Head And Neck Neoplasms - Therapy
(6)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection

Differential expression and prognostic value of long non‐coding RNA in HPV‐negative head and neck squamous cell carcinoma

Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors

COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective

Papillomavirus E6 and E7 proteins and their cellular targets

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy

A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo

Managing Recurrent Metastatic Head and Neck Cancer

Future directions and treatment strategies for head and neck squamous cell carcinomas

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia

Improving Radiotherapy Response in the Treatment of Head and Neck Cancer

A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges

Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole

Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer

The human DEK oncogene regulates DNA damage response signaling and repair

Aktive Filter

Suchergebnisse filtern